Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Norton

Showing results (221-230 of 305) with videos related to

Pageof 31
Sort By:
Plos One|April 3, 2020
Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activityYi Pan, Sam Norton, James M Gwinnutt, et al.
Rheumatology (Oxford, England)|April 16, 2019
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Benjamin D Clarke, Andrew I Rutherford, et al.
Plos One|May 21, 2019
Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activityYi Pan, Sam Norton, James M Gwinnutt, et al.
Rheumatology (Oxford, England)|April 19, 2026
The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023Samir Patel, Mark D Russell, Katie Bechman, et al.
Aging & Mental Health|March 26, 2025
Evaluating a digital mental health intervention for people with Parkinson's (PACT): acceptability and feasibility randomised controlled trialCathryn Pinto, Sam Norton, Patricia Cubi-Molla, et al.
Trials|November 1, 2024
Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysisNarayan Karunanithy, Sam Norton, Francis Calder, et al.
British Journal of Health Psychology|January 8, 2025
Characteristics of refractory disease and persistent symptoms in inflammatory arthritis: Qualitative framework analysis of interviews with patients and health care professionalsHema Chaplin, Carol Simpson, Kate Wilkins, et al.
BMJ Open|September 24, 2017
Understanding barriers and outcomes of unspecified (non-directed altruistic) kidney donation from both professional's and patient's perspectives: research protocol for a national multicentre mixed-methods prospective cohort studyRebecca Gare, Petrut Gogalniceanu, Hannah Maple, et al.
Rheumatology (Oxford, England)|February 24, 2025
Abatacept and the risk of malignancy: a meta-analysis across disease indicationsBenjamin P Zuckerman, Mark Gibson, Ritika Roy, et al.
Rheumatology (Oxford, England)|January 16, 2023
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohortMaryam A Adas, Mark D Russell, Emma Cook, et al.
Pageof 31

Showing results (221-230 of 305) with videos related to

Sort By:
Pageof 31
Plos One|April 3, 2020
Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activityYi Pan, Sam Norton, James M Gwinnutt, et al.
Rheumatology (Oxford, England)|April 16, 2019
Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid ArthritisKatie Bechman, Benjamin D Clarke, Andrew I Rutherford, et al.
Plos One|May 21, 2019
Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activityYi Pan, Sam Norton, James M Gwinnutt, et al.
Rheumatology (Oxford, England)|April 19, 2026
The incidence, mortality and complications of systemic lupus erythematosus: a population-level cohort study from 2012 to 2023Samir Patel, Mark D Russell, Katie Bechman, et al.
Aging & Mental Health|March 26, 2025
Evaluating a digital mental health intervention for people with Parkinson's (PACT): acceptability and feasibility randomised controlled trialCathryn Pinto, Sam Norton, Patricia Cubi-Molla, et al.
Trials|November 1, 2024
Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysisNarayan Karunanithy, Sam Norton, Francis Calder, et al.
British Journal of Health Psychology|January 8, 2025
Characteristics of refractory disease and persistent symptoms in inflammatory arthritis: Qualitative framework analysis of interviews with patients and health care professionalsHema Chaplin, Carol Simpson, Kate Wilkins, et al.
BMJ Open|September 24, 2017
Understanding barriers and outcomes of unspecified (non-directed altruistic) kidney donation from both professional's and patient's perspectives: research protocol for a national multicentre mixed-methods prospective cohort studyRebecca Gare, Petrut Gogalniceanu, Hannah Maple, et al.
Rheumatology (Oxford, England)|February 24, 2025
Abatacept and the risk of malignancy: a meta-analysis across disease indicationsBenjamin P Zuckerman, Mark Gibson, Ritika Roy, et al.
Rheumatology (Oxford, England)|January 16, 2023
COVID-19 admissions and mortality in patients with early inflammatory arthritis: results from a UK national cohortMaryam A Adas, Mark D Russell, Emma Cook, et al.
Pageof 31